Plasma‐Activated Medium Inhibits Tumor Growth in Patient‐Derived Organoids and Xenograft Models of Colorectal and Lung Cancer
The application of cold atmospheric plasma (CAP) and its derivative plasma‐activated medium (PAM) represents a promising approach for cancer therapy. However, conventional 2D cultures fail to recapitulate the structural complexity and heterogeneity of native tumors. In this study, we established patient‐derived organoi...